About Mary Patterson, M.S.

Mary Patterson is a clinical and operational leader with more than a decade of experience advancing medical technologies through clinical research and regulatory strategy. Her expertise spans neuroscience, Alzheimer’s disease, and neurovascular research, with a focus on translating evidence-based science into regulated, real-world medical products.

She has led large-scale Phase I–IV IDE and IND clinical trials through FDA premarket pathways, including programs that achieved Breakthrough Device designation, 510(k) clearance, and CE Mark approval. Her work has included collaboration with global industry partners such as Stryker Neurovascular, Cerenovus, Genentech, and Medtronic.

Clinical & Research Focus

• Alzheimer’s disease and related dementias
• Neurovascular disease and stroke
• Clinical research for cognitive health technologies

Expertise

Clinical focus areas

• Neuroscience
• Alzheimer’s disease
• Dementia
• Neurovascular disease

Regulatory & Trial Experience

• Phase I–IV IDE and IND clinical trials
• FDA Breakthrough Device designation
• 510(k) clearance
• CE Mark approval

Education

• B.A., Neuroscience, Ohio University, magna cum laude
• M.S., Aging and Neuroscience, University of South Florida, magna cum laude
  

Role in BrainCheck Content

Mary authors and reviews BrainCheck content related to Alzheimer’s disease, cognitive assessment, and clinical research. She helps ensure that BrainCheck’s clinical and educational materials reflect current evidence, regulatory expectations, and best practices in cognitive health.

Mary Patterson is an employee of BrainCheck and does not receive additional compensation from third-party device manufacturers for the content on this site.